What are the recent financial highlights of PTC INDIA FIN SERV LTD?

PTC INDIA FIN SERV LTD recently reported a total revenue of ₹357.68 Cr and a net profit margin of 48.29%. These metrics reflect the company’s consistent financial performance.

What are the key financial metrics of PTC INDIA FIN SERV LTD?

Key financial metrics include a trailing P/E ratio of 11.205224, forward P/E of 4.9636364, book value of ₹41.113, price-to-book ratio of 0.73042595, and a market capitalization of ₹19.37 billion.

What does PTC INDIA FIN SERV LTD do?

PTC India Financial Services Limited, a non-banking finance company, provides various financing solutions primarily in India. It offers fund based/non-fund based financial assistance in the form of debt or structured debt instruments, such as term debt or project debt, corporate debt, bridge debt, and bills discounting, as well as letters of comfort, credit enhancement schemes, and deferred payment guarantees. The company acts as underwriter, lead FI, syndicator, security and facility agent, project appraiser, and DPR consultant/preparer. In addition, it invests in green-field and brown-field projects, logistics, road project, and other infrastructure. The company was incorporated in 2006 and is based in New Delhi, India. PTC India Financial Services Limited is a subsidiary of PTC India Limited.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Pfs

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Pfs

Latest updates related to Pfs

Sr No.	Title	Sentiment
1	Rezivertinib Improves PFS vs Gefitinib in EGFR-Mutant NSCLC Cancer Network	🔄
2	Abemaciclib/Fulvestrant Improves PFS Across HR+/HER2– Advanced Breast Cancer Subgroups OncLive	🔄
3	Frontline Camizestrant Combo Increases PFS In Breast Cancer Subtypes www.oncnursingnews.com/	🔄
4	CROWN 5-Year Subgroup Analysis Shows PFS Is Consistent With Overall Patient Population DocWire News	🔄
5	Roche’s Vabysmo prefilled syringe (PFS) approved in the EU for three retinal conditions that can cause blindness Roche	🔄
6	Imulnestrant Plus Abemaciclib Extends PFS Over SOC in ER+/HER2– Advanced Breast Cancer OncLive	🔄
7	Camizestrant Plus CDK4/6 Inhibitors Shows PFS Benefit in HR+/HER2- Breast Cancer Targeted Oncology	🔄
8	PTC India Financial Services Limited (NSE:PFS) Doing What It Can To Lift Shares Simply Wall St	🔄
9	Avelumab prolongs OS, PFS in advanced urothelial carcinoma irrespective of diabetes status Urology Times	🔄
10	PTC CMD, former PFS MD barred from boards, managements of listed companies Mint	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Loading...

Loading...

Stock News - Pfs

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Credit ratings

Concalls

Explore More Stocks